PTEN and cancer: Furthermore, CCSCs and brain CSCs acquire mutations in oncogenes and tumor suppressor genes such as PTEN, TP53 and RB1, which confer them different abilities including: stemness, producing actively proliferating cancer progenitor cells in their niches, multidrug and apoptosis resistance and enhanced DNA repair capacity [196,233].